Global Cetirizine Hydrochloride Market Growth 2023-2029

Global Cetirizine Hydrochloride Market Growth 2023-2029

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria. It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

LPI (LP Information)' newest research report, the “Cetirizine Hydrochloride Industry Forecast” looks at past sales and reviews total world Cetirizine Hydrochloride sales in 2022, providing a comprehensive analysis by region and market sector of projected Cetirizine Hydrochloride sales for 2023 through 2029. With Cetirizine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cetirizine Hydrochloride industry.

This Insight Report provides a comprehensive analysis of the global Cetirizine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cetirizine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cetirizine Hydrochloride market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cetirizine Hydrochloride and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cetirizine Hydrochloride.

The global Cetirizine Hydrochloride market size is projected to grow from US$ 820.9 million in 2022 to US$ 927.8 million in 2029; it is expected to grow at a CAGR of 927.8 from 2023 to 2029.

The major players in the industry are J & J, UCB Pharma, GSK, etc. The proportion of revenue in 2019 is 29.00%, 25.87%, 11.39%. North America has the highest market share by region, accounting for more than 33.8 percent of revenue.

This report presents a comprehensive overview, market shares, and growth opportunities of Cetirizine Hydrochloride market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Tablet

Capsule

Solution

Segmentation by application

Hospital

Drug Store

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

J & J

UCB Pharma

GSK

Teva

HUAPONT Pharm

Sun Pharma

Hunan Jiudian Pharm

Lunan Pharma

Mylan

Apotex

Jubilant Life Sciences

HAILISHENG

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cetirizine Hydrochloride market?

What factors are driving Cetirizine Hydrochloride market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cetirizine Hydrochloride market opportunities vary by end market size?

How does Cetirizine Hydrochloride break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.